SCHEMBL22509494

SCHEMBL22509494

OBc1ccc(Cl)c(F)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAPGEF4 Q8WZA2 1/20 0.34
▸ MAPT P10636 3/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ KMO O15229 2/20 0.33
▸ KCNQ3 O43525 2/20 0.33
▸ KCNQ2 O43526 2/20 0.33
▸ KCNE1 P15382 2/20 0.33
▸ KCNQ1 P51787 2/20 0.33
▸ KCNQ5 Q9NR82 1/20 0.33
▸ SLC6A3 Q01959 3/20 0.33
▸ PPARG P37231 1/20 0.32
▸ PPARA Q07869 1/20 0.32
▸ SLC2A1 P11166 1/20 0.32
▸ TTR P02766 1/20 0.31
▸ HSD17B10 Q99714 2/20 0.31
▸ SLC6A4 P31645 3/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ MAOB P27338 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14140382 0.82 KMT2A (0.42) RAPGEF4MAPTSLC2A1ALDH1A1MEN1
SCHEMBL8042030 0.78 HSD17B10 (0.46) TTRHSD17B10ALDH1A1CYP3A4TSHR
SCHEMBL10187271 0.78 CES2 (0.41) —
SCHEMBL16229877 0.74 CA1 (0.54) MAPK1HSD17B10ALDH1A1MEN1KMT2A
SCHEMBL21417380 0.73 ALDH1A1 (0.50) HSD17B10ALDH1A1CYP3A4
SCHEMBL14135197 0.73 MCL1 (0.38) MAPTSLC6A3TTRHSD17B10ALDH1A1
SCHEMBL25559544 0.73 — —
SCHEMBL22781556 0.73 MAP4K4 (0.40) MAPTHSD17B10ALDH1A1TSHRTDP1
SCHEMBL13191461 0.73 HDAC1 (0.41) MAPTKMOHSD17B10ALDH1A1MEN1
SCHEMBL18964945 0.72 HTR3E (0.47) RAPGEF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3766885-B1 TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS PFIZER (US) 2022-05-25 — — EP disclosed
WO-2021238587-A1 MICROMOLECULAR OXATHIAZINE DERIVATIVE AND USE THEREOF 四川大学华西医院 2021-12-02 — — WO disclosed
EP-3766885-A1 TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS Pfizer Inc (US) 2021-01-20 — — EP disclosed
EP-3310784-B1 TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS. PFIZER (US) 2020-10-07 — — EP disclosed
Send feedback